… in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone, aripiprazole, quetiapine, and …
M Gómez-Revuelta, JM Pelayo-Terán… - International Journal …, 2020 - academic.oup.com
… may be a key point to optimize treatment in patients suffering a first episode of psychosis to
… is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, …
… is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, …
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 …
G Ostuzzi, F Bertolini, F Tedeschi, G Vita… - World …, 2022 - Wiley Online Library
… of extrapyramidal symptoms; haloperidol-OS, haloperidol-LAI … 3-monthly, risperidone-LAI,
risperidone-OS and paliperidone-… in preventing relapse and re-hospitalization as compared to …
risperidone-OS and paliperidone-… in preventing relapse and re-hospitalization as compared to …
Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis
… compared fixed doses of a second-generation antipsychotic, haloperidol, or fluphenazine for
relapse prevention … 5-mg/d risperidone equivalent may provide limited additional benefit for …
relapse prevention … 5-mg/d risperidone equivalent may provide limited additional benefit for …
Better evidence for pharmacological maintenance treatment in nonaffective psychoses: implications for relapse prevention
WG Honer - American Journal of Psychiatry, 2021 - Am Psychiatric Assoc
… in preventing relapse (risk difference… (haloperidol used in 10 of 11 studies, risk
difference=−0.11, 95% CI=−0.15 to −0.07) (11). A meta-analysis of randomized controlled trials …
difference=−0.11, 95% CI=−0.15 to −0.07) (11). A meta-analysis of randomized controlled trials …
Comparison of relapse prevention with 3 different paliperidone formulations in patients with schizophrenia continuing versus discontinuing active antipsychotic …
M Mathews, S Gopal, A Singh, I Nuamah… - Neuropsychiatric …, 2020 - Taylor & Francis
… the three studies to compare the time-to-relapse and related change in efficacy scales, in
patients suddenly discontinuing antipsychotics (patients randomized to placebo groups) vs …
patients suddenly discontinuing antipsychotics (patients randomized to placebo groups) vs …
Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised …
M Højlund, AF Kemp, PM Haddad, JC Neill… - The Lancet …, 2021 - thelancet.com
… We aimed to compare risks and benefits of reduced versus standard doses of antipsychotics.
… Does cognitive function improve with quetiapine in comparison to haloperidol?. …
… Does cognitive function improve with quetiapine in comparison to haloperidol?. …
Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: rationale and design of a prospective, randomized, 3-phase …
J Mayoral-van Son, M Gómez-Revuelta… - Revista de psiquiatría y …, 2021 - Elsevier
… ) comparing the effectiveness of aripiprazole and risperidone, and to … compare head-to-head
neurocognitive effectiveness of aripiprazole and risperidone in the treatment of FEP patients…
neurocognitive effectiveness of aripiprazole and risperidone in the treatment of FEP patients…
Comparative effectiveness of antipsychotics in preventing readmission for first-admission schizophrenia patients in national cohorts from 2001 to 2017 in Taiwan
… patients (62.05%) had at least one readmission within 4 years. Compared to the period under
treatment with oral risperidone, … 3 LAIs (haloperidol, flupentixol, and risperidone) exhibited …
treatment with oral risperidone, … 3 LAIs (haloperidol, flupentixol, and risperidone) exhibited …
Randomized controlled trial of paliperidone extended release versus risperidone for the treatment of methamphetamine-associated psychosis in Chinese patients
G Wang, F Ding, MC Chawarski, W Hao, X Liu… - Frontiers in …, 2020 - frontiersin.org
… as aripiprazole, risperidone, haloperidol, and quetiapine, are effective for patients with MAP,
… role in the excretion of paliperidone ER compared with risperidone, which may reduce the …
… role in the excretion of paliperidone ER compared with risperidone, which may reduce the …
Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta …
JM Rubio, G Schoretsanitis, M John, J Tiihonen… - The Lancet …, 2020 - thelancet.com
… which reported that 18·3% of participants receiving risperidone LAI relapsed. Although …
acute psychosis and preventing relapse compared with no treatment, but patients whose illness is …
acute psychosis and preventing relapse compared with no treatment, but patients whose illness is …